Navigation Links
Acquisition of Devices, Methods and Intellectual Property Support Leadership Position in Regenerative Therapies
Date:7/22/2013

AUSTIN, Texas, July 22, 2013 /PRNewswire/ -- On Wednesday, July 17th, Celling Biosciences made an asset acquisition of devices, proprietary methods and intellectual property from Orogen Biosciences.  Orogen, based out of Sarasota, Florida, was an early innovator in processing platelet rich plasma (PRP) and concentrating growth factors and cytokines to optimize the most effective and efficient methods for providing therapeutic treatments with a patient's own tissue.   With this acquisition, Celling is furthering its position as a leader of point of care, autologous cell therapy. 

Celling is focused on the three pillars of regenerative medicine (cells, substrates, and signals) known to enhance the environment for tissue repair, regeneration, and revascularization.  The devices (OPC and ACE) and methods from Orogen provide physicians with access to a patient's own growth factors and proteins to support the healing cascade.  There is a growing body of evidence in the literature of the role growth factors play in optimizing the healing in multiple pathologies across medicine.  The OPC device allows physicians to process autologous plasma at the point of care to deliver concentrated growth factors when compared to currently marketed options.  The ACE device is a unique technology that produces an enriched preparation of growth factors without the presence of white blood cells, red blood cells or platelets. 

Additionally, Celling has acquired methods and devices for delivering allogeneic products to the veterinary market. Based on the short and long term success of these products in treating horses and canines in soft tissue repair, Celling will be well positioned to penetrate the veterinary market which is leading human efforts into the emerging market of regenerative medicine.   

Celling has begun the process of transitioning Orogen revenues, opening a Florida office and launching devices to the market within the next quarter.  "We believe this is a unique opportunity for Celling to keep building our product and services portfolio in the autologous space.  We continue to expand our registered nurse service model across the country anticipating the orchestrated event in cell therapy between physicians and technology providers.  This acquisition is another step in adding sophistication to the process," says Kevin Dunworth, CEO and Founder of Celling Biosciences. We had a number of companies approach us about acquiring Orogen's intellectual property but we were waiting on the right fit both culturally and philosophically based on who we believed to be a leader in cell therapy innovation.  "We are extremely excited about this development and are confident that Celling Biosciences has the vision to create significant value in the regenerative medicine space," says Ryan Brandt, President of Orogen.  

About Celling Biosciences
Celling Biosciences is an Austin, Texas based company working closely with world leaders in academia, medicine, scientists and engineers to research and develop innovative technologies in the emerging field of regenerative medicine.  Celling's product-offering focuses on autologous cell therapy and the devices and services that compliment these procedures.  For more information please visit: www.cellingbiosciences.com.

Troy Wilford
twilford@cellingbiosciences.com


'/>"/>
SOURCE Celling Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. DTx to Introduce Data Acquisition Control & Robotic Instrument (DACRI) at Clinical Lab Expo in Houston, TX.
2. Techne Corporation Announces Acquisition Agreement
3. Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
4. PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy
5. Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
6. bioRASI Completes Acquisition of Ukrainian CRO
7. BGI-Shenzhen Completes Acquisition of Complete Genomics
8. Biotrial, a Leading Provider of Drug Development Services, Has Completed its Acquisition of Warnex Bioanalytical Services Division
9. Inflamax Research Introduces Electronic Patient Data Acquisition Tablet™ (ePDAT)™ for Real-Time PRO Data Collection
10. DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies
11. Haemonetics Reports First Quarter Fiscal 2013 Results, Completes Acquisition of Palls Transfusion Medicine Business, Affirms Fiscal 2013 Earnings Guidance, Provides Preliminary Outlook for Fiscal 2014 and Announces Share Repurchase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ... of clinical trials will cause long-term harm , Contrary to conventional wisdom that ... Institute study finds many companies will emerge from the pandemic commercially weaker, ...
(Date:5/15/2020)... ... May 14, 2020 , ... RoosterBio ... banks and hMSC bioprocess systems, today announced the launch of its product ... vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with hMSC-EV product developers ...
(Date:5/14/2020)... Del. (PRWEB) , ... May 12, 2020 , ... ... of Interdisp JCS as the new distribution partner for all personal care ingredients ... DuPont GENENCARE®OSMS portfolio and DuPont preservative portfolio for personal care. , The ...
(Date:5/9/2020)... ... May 08, 2020 , ... Worldwide Business with ... successful business program on Sunday, May 10, 2020 and Wednesday, May 13, 2020 at ... episode’s exclusive interviews will spotlight key executives from Techolution and Bravado ...
Breaking Biology Technology:
(Date:5/14/2020)... ... May 14, 2020 , ... The annual salary report ... the 2019 average medical sales rep total compensation increased by $12,000 over the ... the COVID-19 global crisis. , The MedReps 2020 Salary Survey revealed yet again ...
(Date:5/1/2020)... ... April 30, 2020 , ... USARAD Holdings Inc., ... several healthcare VC firms announces an official launch of CareDoctors.com. In an effort ... patient care experience by offering live video consultations with board certified physicians in ...
(Date:4/30/2020)... ... 28, 2020 , ... Pebble Labs USA Inc. , a biotechnology company ... with the mission of improving global food security, announced today that they have been ... in Food- and Ag-Tech ' virtual event, a global initiative to drive innovation in ...
Breaking Biology News(10 mins):